Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin X Chen

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappingsKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Stroke|November 15, 2011
Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injuryArt Riddle, Jennifer Maire, Xi Gong, et al.
Bioorganic & Medicinal Chemistry|November 23, 2007
Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residueKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Angewandte Chemie (International Ed. in English)|October 8, 2005
Proline-based macrocyclic inhibitors of the hepatitis C virus: stereoselective synthesis and biological activityKevin X Chen, F George Njoroge, Bancha Vibulbhan, et al.
Drug Metabolism Letters|December 10, 2009
The role of P-glycoprotein in the pharmacokinetics and tissue distribution of a hepatitis C virus protease inhibitorKevin X Chen, Bancha Vibulbhan, Tongtong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profileLatha G Nair, Mousumi Sannigrahi, Stephane Bogen, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine proteaseAshok Arasappan, F George Njoroge, Kevin X Chen, et al.
Journal of Medicinal Chemistry|February 3, 2006
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocyclesKevin X Chen, F George Njoroge, Ashok Arasappan, et al.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Journal of Medicinal Chemistry|April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profileAshok Arasappan, Angela I Padilla, Edwin Jao, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry Letters|January 27, 2009
Novel potent inhibitors of hepatitis C virus (HCV) NS3 protease with cyclic sulfonyl P3 cappingsKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Stroke|November 15, 2011
Differential susceptibility to axonopathy in necrotic and non-necrotic perinatal white matter injuryArt Riddle, Jennifer Maire, Xi Gong, et al.
Bioorganic & Medicinal Chemistry|November 23, 2007
Potent and selective small molecule NS3 serine protease inhibitors of Hepatitis C virus with dichlorocyclopropylproline as P2 residueKevin X Chen, Bancha Vibulbhan, Weiying Yang, et al.
Angewandte Chemie (International Ed. in English)|October 8, 2005
Proline-based macrocyclic inhibitors of the hepatitis C virus: stereoselective synthesis and biological activityKevin X Chen, F George Njoroge, Bancha Vibulbhan, et al.
Drug Metabolism Letters|December 10, 2009
The role of P-glycoprotein in the pharmacokinetics and tissue distribution of a hepatitis C virus protease inhibitorKevin X Chen, Bancha Vibulbhan, Tongtong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|December 17, 2009
P4 capped amides and lactams as HCV NS3 protease inhibitors with improved potency and DMPK profileLatha G Nair, Mousumi Sannigrahi, Stephane Bogen, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2006
P2-P4 macrocyclic inhibitors of hepatitis C virus NS3-4A serine proteaseAshok Arasappan, F George Njoroge, Kevin X Chen, et al.
Journal of Medicinal Chemistry|February 3, 2006
Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocyclesKevin X Chen, F George Njoroge, Ashok Arasappan, et al.
Cancer Research Communications|September 4, 2023
Discovery and Characterization of ZL-2201, a Potent, Highly Selective, and Orally Bioavailable Small-molecule DNA-PK InhibitorShruti Lal, Neil E Bhola, Bee-Chun Sun, et al.
Journal of Medicinal Chemistry|April 18, 2009
Toward second generation hepatitis C virus NS3 serine protease inhibitors: discovery of novel P4 modified analogues with improved potency and pharmacokinetic profileAshok Arasappan, Angela I Padilla, Edwin Jao, et al.
Pageof 4